REBIRTH Study
REBIRTH Observational Cohort: Evaluation of Myocardial Recovery in Breastfeeding Women with Peripartum Cardiomyopathy
GENDER: Female
HEALTHY PARTICIPANTS: No
CONDITION: Peripartum Cardiomyopathy, Postpartum
Learn More
For more information, please contact the study coordinator, Emily Mulenax at 216-844-3852 or complete the form below.
Study Purpose
The purpose of this randomized placebo controlled research study is to evaluate the impact of the investigational drug, bromocriptine, on myocardial recovery and clinical outcomes. Given that bromocriptine prevents breastfeeding, an additional 50 women with peripartum cardiomyopathy excluded from the trial due to a desire to continue breastfeeding but meeting all other entry criteria will be followed in an observational cohort.
Who Can Participate
Participants 18 years and older who are newly diagnosed with peripartum cardiomyopathy post-delivery and within the first 5 months post-partum may be eligible for this study.